Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-03

Clinical Trial Update: A Study of Orally Administered Pimodivir in Adult Participants With Renal Impairment [Phase 1]

View source ↗

Summary

A Phase 1 trial of Pimodivir in adults with chronic kidney disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pimodivir (pimodivir)

Snippet

Sponsor: Janssen-Cilag International NV | Conditions: Kidney Failure, Chronic | Phase 1 | Status: TERMINATED